24 March 2021

Nina Hilkens, Karin Klijn and Edo Richard, theme Disorder of movements, investigated whether blood pressure levels and blood pressure variability influence the risk of post-stroke dementia, in an attempt to find a potential target for prevention of post-stroke dementia. Findings are published in Journal of Hypertension on 11 March 2021.

Improvements in acute treatment of stroke, including removal of a blood clot from the brain, have led to better outcomes and increased survival. But one-third of stroke survivors develop dementia within five years after stroke. There are no effective strategies to prevent or lower the risk of dementia after stroke. High blood pressure and large variation in blood pressure may increase the risk of dementia in patients without stroke.  

They analyzed data from over 17.000 patients with ischemic stroke, who were followed-up for 2.5 years and underwent repeated blood pressure measurements. They found that the risk of dementia is elevated in those patients with high systolic blood pressure, but also in those with low blood pressure, implying a U-shaped association. This may have important implications for future blood pressure management after stroke. It suggests that lower may not always be better.

Furthermore, they observed that higher variability in blood pressure over successive measurements was associated with a linear increase in risk of dementia. Given the variable effect of antihypertensive treatment on blood pressure variability, with stronger effects for specific antihypertensive medication, for instance calcium channel blockers, these findings may impact on the optimal choice of antihypertensive treatment.

These results may inform future randomized controlled trials aiming to optimize blood pressure management after stroke, taking cognitive decline and dementia as important outcomes into account, next to the common outcomes recurrent stroke and mortality, which are not necessarily the outcomes valued most by patients.


Hilkens NA, Klijn CJM, Richard E. Blood pressure, blood pressure variability and the risk of post-stroke dementia. Journal of Hypertension, 2021 Mar 11. doi: 10.1097/HJH.0000000000002841. Online ahead of print.

Related news items

Rogier Kievit and Geert Litjens both receive ERC Starting Grant of 1.5 million euros Board of Directors congratulates researchers on top grant

13 January 2022

Researchers Rogier Kievit and Geert Litjens were today festively welcomed by the Board of Directors, because of the ERC Starting Grants they both received. With these European top grants, they can each design an ambitious research project and put together their own research group.

read more

Improved AI will boost cancer research and cancer care Geert Litjens receives ERC Starting Grant

13 January 2022

Geert Litjens from Radboud university medical center has received a European Research Council (ERC) Starting Grant.

read more

Understanding fluctuation variation in cognitive abilities may provide insight into lifelong learning Rogier Kievit recieves ERC Starting Grant

13 January 2022

Rogier Kievit from Radboud university medical center has received a European Research Council (ERC) Starting Grant.

read more

Looking back on RIMLS New Year celebration and awards

12 January 2022

RIMLS organized a special online New Year Celebration, together looking back at the year 2021. René Bindels reviewed 2021 together with Clasien Oomen and Dagmar Eleveld-Trancikova, looked forward towards 2022 and presented the RIMLS awards and several other prizes.

read more

ody composition is more important than BMI for renal cancer survival rates

11 January 2022

Body composition is important for survival rates in renal cell cancer. Research from the Radboudumc shows that low muscle quality and low organ fat are associated with poor survival. This involves different stages of renal cancer, ranging from stage I-III to stage IV.

read more

Giesje Nefs receives fellowship from the Diabetes Fund

10 January 2022

Diabetes technology - such as insulin pumps, closed loop systems, sensors, smart insulin pens - is evolving enormously. But there are also concerns, or false expectations. Giesje Nefs wants to gain more insight into this so she can help people make their choice.

read more